手紙: 新生児のためのヘキサクロロファンの除塵粉.

Working with Parry sound area local Canadian First Nations to describe a good death and ensure cultural sensitivity at the end-of-life.

BMC palliative care·2025

Providers' perspectives on the reproductive decision-making of BRCA-positive women.

BMC women's health·2022

Pregnancies in women with Turner syndrome: a retrospective multicentre UK study.

BJOG : an international journal of obstetrics and gynaecology·2021

Haemostatic devices in parotid surgery: a systematic review.

The Journal of laryngology and otology·2021

Guiding the rational design of patient-centred drug trials in Cystic Fibrosis: A Delphi study.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2021

Optimising equity of access: how should we allocate slots to the most competitive trials in Cystic Fibrosis (CF)?

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2021

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Correction: Synergistic adsorption of ciprofloxacin on an amine-functionalized Zn-MOF/chitosan-polyethylenimine composite sponge: experimental and statistical optimization and biological activity.

RSC advances·2026

Effective removal of toxic methylene blue dye using ZnO/nanolignin composite: kinetic, isotherm and thermodynamic study.

BMC chemistry·2026

ZDHHC8-mediated S-palmitoylation of RAD21 causes mitochondrial dysfunction in diabetic nephropathy via inhibiting ACSM3 transcription.

Cell death and differentiation·2026

Dual-pathway mask ranking guided selective fine-tuning for backdoor purification.

Neural networks : the official journal of the International Neural Network Society·2026

Rosuvastatin-Metformin Co-Processing: Enhanced Dissolution, Oral Bioavailability, and Therapeutic Efficacy through a Solvent-Minimized Approach.

Drug development and industrial pharmacy·2026

First-in-human study on the pharmacokinetics, safety, and tolerability of single escalating doses and multiple doses of XT1061, a novel core protein allosteric modulator, in healthy Chinese subjects.

Frontiers in pharmacology·2026

関連する実験動画

手紙: 新生児のためのヘキサクロロファンの除塵粉.

関連する概念動画

Working with Parry sound area local Canadian First Nations to describe a good death and ensure cultural sensitivity at the end-of-life.

Providers' perspectives on the reproductive decision-making of BRCA-positive women.

Pregnancies in women with Turner syndrome: a retrospective multicentre UK study.

Haemostatic devices in parotid surgery: a systematic review.

Guiding the rational design of patient-centred drug trials in Cystic Fibrosis: A Delphi study.

Optimising equity of access: how should we allocate slots to the most competitive trials in Cystic Fibrosis (CF)?

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Correction: Synergistic adsorption of ciprofloxacin on an amine-functionalized Zn-MOF/chitosan-polyethylenimine composite sponge: experimental and statistical optimization and biological activity.

Effective removal of toxic methylene blue dye using ZnO/nanolignin composite: kinetic, isotherm and thermodynamic study.

ZDHHC8-mediated S-palmitoylation of RAD21 causes mitochondrial dysfunction in diabetic nephropathy via inhibiting ACSM3 transcription.

Dual-pathway mask ranking guided selective fine-tuning for backdoor purification.

Rosuvastatin-Metformin Co-Processing: Enhanced Dissolution, Oral Bioavailability, and Therapeutic Efficacy through a Solvent-Minimized Approach.

First-in-human study on the pharmacokinetics, safety, and tolerability of single escalating doses and multiple doses of XT1061, a novel core protein allosteric modulator, in healthy Chinese subjects.

関連する実験動画

手紙: 新生児のためのヘキサクロロファンの除塵粉.

関連する概念動画

関連記事